Send the link below via email or IMCopy
Present to your audienceStart remote presentation
- Invited audience members will follow you as you navigate and present
- People invited to a presentation do not need a Prezi account
- This link expires 10 minutes after you close the presentation
- A maximum of 30 users can follow your presentation
- Learn more about this feature in our knowledge base article
Warkany Syndrome (Trisomy 8)
Transcript of Warkany Syndrome (Trisomy 8)
Blood chromosome testing
Skin biopsies The symptoms are most likely to deal with:
Narrow bone stucture
Heart defects This syndrome is also known to cause 0.8% of infant deaths. Warkany syndrome even has a frequency of 1 to 25,000 and 1 to 50,000 births and is mainly seen in male babies. Treatment No cure for Warkany Syndrome has been discovered, but there are a few ways to treat some of the disabilities. Many of the physical flaws from Warkany syndrome can be restructured through surgery or like:
Undescended Testicles Other characteristics of Warkany Syndrome cause no potential harm to the body at all such as:
Change in bone structure Vuong, L. (2011, October 26). Estybon may be effective as salvage therapy for higher-risk mds patients and patients with trisomy 8. The MDS Beacon. Retrieved from http://www.mdsbeacon.com/news/2011/10/26/estybon-rigosertib-may-be-effective-as-salvage-therapy-for-higher-risk-mds-patients-and-patients-with-trisomy-8/.
Signs of trisomy 8 mosaicism. (2012., Nov. 06) Retrieved from http://www.rightdiagnosis.com/t/trisomy_8_mosaicism/signs.htm.
Trisomy 8 mosaicism syndrome. (n.d.). Retrieved from http://www.healthline.com/galecontent/trisomy-8-mosaicism-syndrome.
Trisomy 8. (n.d). Retrived from http://diseasedisease.com/Syndrome/Trisomy-8.html.
Vuong, L. (2012, September, 04). Vidaza may help certain lower-risk mds patients transfusion independence (eha 2012) The MDS Beacon. Retrieved from http://www.mdsbeacon.com/news/2012/09/04/vidaza-azaciticline-lower-risk-mds-transfusion-eha-2012/.
Haehle, M. (2012, November 07). Potential new mds treatments: What is on the horizon?. The MDS Beacon. Retrieved from http://www.mdsbeacon.com/news/2012/11/07/new-mds-myelodysplastic-syndromes-treatments/.
J3, L. (2012, Feburary 14). Oral estybon shows activity in myelodysplastic syndromes (ash 2011). The MDS Beacon. Retrieved from http://www.mdsbeacon.com/news/2012/02/14/oral-estybon-rigosertib-shows-activity-in-myelodysplastic-syndromes-ash-2011/. The research involved MDS Trisomy 8 patients to incorperate Vidaza and Estybon in their transfusion cycles. The purpose for Vidaza was to complete their blood transfusion and Estybon to stablalize the amount of mutated Trisomy 8 blood cells. Most people suspect that their child has warkany syndrome because the child born has rare characteristics like:
Uneven leg lenghts
Deep creases in the feet and hands
Vidaza and Estybon are similar drugs as they both can be used to prevent cell growth and kill cancerous cells. The only difference is that Estybon is an experimental drug. In the Vidaza study twenty-nine cases were reported with serious side effects from sixteen patients who had infection. With the Estybon study two out of the six patients managed a stable Trisomy 8 blood count. The rest of the four patients had serious side effects such as:
fatigue and nosebleeds